Rabbit Polyclonal MLYCD/MCD antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human MLYCD.
View Alternative Names
MCD, MLYCD
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MLYCD/MCD antibody (AB234879)
HepG2 (human liver hepatocellular carcinoma cell line) cells labeling MLYCD/MCD (green) using ab234879 at 1/100 dilution in ICC/IF, followed by Alexa Fluor 488® conjugated Goat Anti-Rabbit IgG (H+L).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MLYCD/MCD antibody (AB234879)
Paraffin-embedded human heart tissue stained for MLYCD/MCD using ab234879 at 1/100 dilution in immunohistochemical analysis.
- WB
Supplier Data
Western blot - Anti-MLYCD/MCD antibody (AB234879)
All lanes:
Western blot - Anti-MLYCD/MCD antibody (ab234879) at 1/2000 dilution
All lanes:
HEK-293 (human epithelial cell line from embryonic kidney) cell lysate
Secondary
All lanes:
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 55 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MLYCD converts malonyl-CoA an inhibitor of mitochondrial fatty acid oxidation into acetyl-CoA. This conversion permits fatty acids to enter mitochondria for beta-oxidation. It is not typically part of larger protein complexes but can interact with other molecules regulating lipid metabolism. Through these interactions it indirectly influences cellular energy balance and lipid biosynthesis.
Pathways
MLYCD is involved in the fatty acid metabolism pathway and energy homeostasis. Within these it serves as a regulatory point influencing the balance between fat utilization and storage. MLYCD maintains balance alongside proteins such as carnitine palmitoyltransferase 1A (CPT1A) which controls the entry of fatty acids into mitochondria for beta-oxidation linking these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cancer research 83:3920-3939 PubMed37729394
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell 185:3356-3374.e22 PubMed36055199
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com